NeuroScientific has completed its acquisition of Perth pharmaceuticals company Isopogen WA, which controls the StemSmart technology patent, in a bid to boost its stem cell offerings.

NeuroScientific has completed its acquisition of Perth pharmaceuticals company Isopogen WA, which controls the StemSmart technology patent, in a bid to boost its stem cell offerings.